Genscript Biotech Corporation (HKG:1548)
Hong Kong flag Hong Kong · Delayed Price · Currency is HKD
12.36
+0.51 (4.30%)
Apr 2, 2026, 4:08 PM HKT

Genscript Biotech Ratios and Metrics

Millions HKD. Fiscal year is Jan - Dec.
Fiscal Year
CurrentFY 2025FY 2024FY 2023FY 2022FY 2021
Period Ending
Apr '26 Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
27,02527,15521,09742,16652,56372,496
Market Cap Growth
-1.68%28.72%-49.97%-19.78%-27.50%229.03%
Enterprise Value
23,43024,13718,90638,02247,67064,744
Last Close Price
12.3612.429.8419.8624.8534.50
PE Ratio
--0.92---
Forward PE
41.7241.99----
PS Ratio
3.623.644.579.6310.7718.97
PB Ratio
0.880.880.632.644.956.70
P/TBV Ratio
0.880.880.633.946.859.25
P/FCF Ratio
14.3714.44----
P/OCF Ratio
10.6710.7235.90---
PEG Ratio
-2.522.522.522.522.52
EV/Sales Ratio
3.143.234.098.689.7716.94
EV/EBITDA Ratio
-9.7434.7558.29--
EV/EBIT Ratio
-12.15262.23185.81--
EV/FCF Ratio
12.4612.83----
Debt / Equity Ratio
0.090.090.170.410.480.30
Debt / EBITDA Ratio
1.051.058.518.59--
Debt / FCF Ratio
1.431.43----
Net Debt / Equity Ratio
-0.12-0.120.02-0.53-0.59-0.71
Net Debt / EBITDA Ratio
-1.47-1.471.46-13.002.082.89
Net Debt / FCF Ratio
-1.93-1.93-0.852.012.403.66
Asset Turnover
0.190.190.140.190.260.27
Inventory Turnover
11.5011.507.645.126.175.46
Quick Ratio
1.311.312.464.502.993.80
Current Ratio
1.501.502.724.763.233.97
Return on Equity (ROE)
-12.85%-12.85%-5.46%9.56%-31.12%-47.05%
Return on Assets (ROA)
3.15%3.15%0.13%0.55%-11.45%-12.88%
Return on Invested Capital (ROIC)
7.30%6.44%0.34%3.34%-91.80%-152.50%
Return on Capital Employed (ROCE)
6.20%6.20%0.20%0.90%-21.90%-20.80%
Earnings Yield
-15.35%-15.27%109.05%-1.77%-3.36%-3.86%
FCF Yield
6.96%6.93%-4.42%-9.99%-4.99%-2.90%
Buyback Yield / Dilution
0.50%0.50%-3.27%-0.58%-3.28%-6.83%
Total Shareholder Return
0.50%0.50%-3.27%-0.58%-3.28%-6.83%
Updated Dec 31, 2025. Source: S&P Global Market Intelligence. Standard template. Financial Sources.